120 related articles for article (PubMed ID: 25338606)
1. [Advances of treatment for nature killer/T-cell lymphoma].
Wang H; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1453-8. PubMed ID: 25338606
[TBL] [Abstract][Full Text] [Related]
2. Novel therapy for NK/T cell lymphoma.
Xu XX; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1501-6. PubMed ID: 23257462
[TBL] [Abstract][Full Text] [Related]
3. [Advances of treatment for extranodal NK/T-cell lymphoma --- review].
Zhang SS; Wei M; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1075-8. PubMed ID: 21867647
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
5. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
6. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
7. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
8. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
Vose J; Armitage J; Weisenburger D;
J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract.
Hahn JS; Lee ST; Min YH; Ko YW; Yang WI; Kim GE
Yonsei Med J; 2002 Apr; 43(2):175-82. PubMed ID: 11971211
[TBL] [Abstract][Full Text] [Related]
10. Treatment algorithms for mature T-cell and natural killer-cell neoplasms.
Tse E; Kwong YL
Future Oncol; 2011 Sep; 7(9):1101-12. PubMed ID: 21919697
[TBL] [Abstract][Full Text] [Related]
11. Extranodal lymphomas of head and neck with emphasis on NK/T-cell lymphoma, nasal type.
Coha B; Vucinic I; Mahovne I; Vukovic-Arar Z
J Craniomaxillofac Surg; 2014 Mar; 42(2):149-52. PubMed ID: 23688595
[TBL] [Abstract][Full Text] [Related]
12. Management of extranodal natural killer/t-cell lymphoma, nasal type.
Chaudhary RK; Bhatt VR; Vose JM
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):245-52. PubMed ID: 25659751
[TBL] [Abstract][Full Text] [Related]
13. Natural killer-cell malignancies: diagnosis and treatment.
Kwong YL
Leukemia; 2005 Dec; 19(12):2186-94. PubMed ID: 16179910
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation.
Sasaki M; Matsue K; Takeuchi M; Mitome M; Hirose Y
Int J Hematol; 2000 Jan; 71(1):75-8. PubMed ID: 10729998
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy.
Bi XW; Jiang WQ; Zhang WW; Huang JJ; Xia Y; Wang Y; Sun P; Li ZM
Ann Hematol; 2015 Jul; 94(7):1175-84. PubMed ID: 25687842
[TBL] [Abstract][Full Text] [Related]
17. Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.
Tao R; Liu C; Zhang W; Zhu Y; Ma Y; Hao S
Oncologist; 2024 Jan; 29(1):e90-e96. PubMed ID: 37616529
[TBL] [Abstract][Full Text] [Related]
18. Extranodal natural killer/T-cell lymphoma: advances in the management.
Jaccard A; Hermine O
Curr Opin Oncol; 2011 Sep; 23(5):429-35. PubMed ID: 21743325
[TBL] [Abstract][Full Text] [Related]
19. Natural killer/T-cell lymphomas in pediatric and adolescent patients.
Termuhlen AM
Clin Adv Hematol Oncol; 2017 Mar; 15(3):200-209. PubMed ID: 28398275
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
